The Need to Analyze Telogen Effluvium and Alopecia Areata Parallelly in Long COVID Studies
July 2024
in “
Influenza and Other Respiratory Viruses
”
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide → 
Studysummary This study by Kyung et al. found a significant association between SARS-CoV-2 infection and an increased risk of developing alopecia areata in long COVID patients, with COVID-19 severity and vaccination status impacting this risk.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document discusses the importance of analyzing telogen effluvium (TE) and alopecia areata (AA) in parallel when studying long COVID-related hair loss. The authors respond to a study by Kyung et al., which links SARS-CoV-2 infection with an increased risk of AA. They emphasize that TE, characterized by diffuse hair shedding due to stress or illness, is also relevant to COVID-19 but less recognized than AA, leading to potential misclassification. The authors suggest that presenting TE and AA together in research could provide a clearer understanding of hair loss patterns in long COVID. They recommend using dermatologist-confirmed AA diagnoses to improve accuracy and propose comparing hair loss from other viral infections to better understand virus-associated alopecia. Overall, they advocate for a more comprehensive approach to studying post-COVID-19 hair loss to enhance patient care.
